Healthcare provider profile · identity verified

Deepak Setia, MD

Internal Medicine · RIDGEWOOD, NY · NPI 1285640698

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	408	131
Amlodipine Besylate	Amlodipine Besylate	245	84
Levothyroxine Sodium	Levothyroxine Sodium	164	53
Metformin Hcl	Metformin Hcl	131	42
Eliquis	Apixaban	129	35
Tamsulosin Hcl	Tamsulosin Hcl	129	55
Metoprolol Tartrate	Metoprolol Tartrate	119	43
Lisinopril	Lisinopril	118	39
Gabapentin	Gabapentin	116	38
Metoprolol Succinate	Metoprolol Succinate	114	42
Furosemide	Furosemide	110	44
Rosuvastatin Calcium	Rosuvastatin Calcium	104	36
Jardiance	Empagliflozin	102	19
Albuterol Sulfate Hfa	Albuterol Sulfate	91	36
Famotidine	Famotidine	86	36
Pantoprazole Sodium	Pantoprazole Sodium	77	31
Clopidogrel	Clopidogrel Bisulfate	75	24
Simvastatin	Simvastatin	72	31
Donepezil Hcl	Donepezil Hcl	69	25
Omeprazole	Omeprazole	68	22
Hydrochlorothiazide	Hydrochlorothiazide	65	22
Oxycodone Hcl	Oxycodone Hcl	65	14
Losartan Potassium	Losartan Potassium	64	28
Carvedilol	Carvedilol	60	19
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	54	12
Duloxetine Hcl	Duloxetine Hcl	50	11
Sertraline Hcl	Sertraline Hcl	49	22
Ezetimibe	Ezetimibe	45	11
Xarelto	Rivaroxaban	45	suppressed
Januvia	Sitagliptin Phosphate	43	16
Clonazepam	Clonazepam	42	suppressed
Levetiracetam	Levetiracetam	41	18
Mirtazapine	Mirtazapine	39	16
Montelukast Sodium	Montelukast Sodium	39	17
Entresto	Sacubitril/Valsartan	38	13
Ozempic	Semaglutide	38	12
Acetaminophen-Codeine	Acetaminophen With Codeine	37	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	36	29
Farxiga	Dapagliflozin Propanediol	36	suppressed
Warfarin Sodium	Warfarin Sodium	35	suppressed
Alendronate Sodium	Alendronate Sodium	34	12
Alprazolam	Alprazolam	34	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	33	suppressed
Potassium Chloride	Potassium Chloride	33	12
Buspirone Hcl	Buspirone Hcl	32	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	32	suppressed
Diclofenac Sodium	Diclofenac Sodium	31	14
Fluticasone Propionate	Fluticasone Propionate	31	11
Lorazepam	Lorazepam	31	suppressed
Tramadol Hcl	Tramadol Hcl	31	13
Azithromycin	Azithromycin	30	28
Hydralazine Hcl	Hydralazine Hcl	30	12
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Milrinone In 5% Dextrose	Milrinone Lactate/D5w	28	suppressed
Alcohol Prep Pads	Alcohol Antiseptic Pads	27	12
Carbidopa-Levodopa	Carbidopa/Levodopa	26	suppressed
Olanzapine	Olanzapine	26	suppressed
Trazodone Hcl	Trazodone Hcl	26	suppressed
Vascepa	Icosapent Ethyl	26	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	25	25
Enalapril Maleate	Enalapril Maleate	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	25	13
Valsartan	Valsartan	25	suppressed
Prednisone	Prednisone	24	21
Memantine Hcl	Memantine Hcl	23	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	22	suppressed
Lactulose	Lactulose	22	12
Latanoprost	Latanoprost	22	suppressed
Nifedipine Er	Nifedipine	22	12
Atenolol	Atenolol	21	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Bumetanide	Bumetanide	20	suppressed
Glipizide	Glipizide	20	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	20	suppressed
Amiodarone Hcl	Amiodarone Hcl	19	suppressed
Aripiprazole	Aripiprazole	18	suppressed
Meclizine Hcl	Meclizine Hcl	18	suppressed
Spironolactone	Spironolactone	18	suppressed
Baclofen	Baclofen	17	suppressed
Dronabinol	Dronabinol	17	suppressed
Sodium Chloride	0.9 % Sodium Chloride	17	suppressed
Torsemide	Torsemide	17	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Ramipril	Ramipril	16	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	16	suppressed
Allopurinol	Allopurinol	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Fentanyl	Fentanyl	15	suppressed
Lacosamide	Lacosamide	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	suppressed
Chlorthalidone	Chlorthalidone	14	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	14	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	14	suppressed
Anastrozole	Anastrozole	13	suppressed
Insulin Lispro	Insulin Lispro	13	suppressed
Lamotrigine	Lamotrigine	13	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	13	suppressed
Pravastatin Sodium	Pravastatin Sodium	13	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Fenofibrate	Fenofibrate,micronized	11	suppressed
Finasteride	Finasteride	11	suppressed
Ibandronate Sodium	Ibandronate Sodium	11	suppressed
Ibuprofen	Ibuprofen	11	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Oxcarbazepine	Oxcarbazepine	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error